Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05756478

Appropriate Prescribing for Older Adults With Multimorbidity (Pro-M)

Conditions: Potentially Inappropriate Medications, Multimorbidity, Polypharmacy

Sex: All
Ages: 21 Years – 99 Years
Phase: NA
Enrollment: 100
Sponsor: Geriatric Education and Research Institute

Location: Singapore

Summary

This is a two-site feasibility study to test implementation of an intervention that aims to reduce inappropriate prescribing for older adults with multimorbidity in geriatric medicine specialist clinics at public hospitals in Singapore. The specific aims are:To assess the implementation outcomes: Appropriateness, Penetration/Reach, Acceptability, Feasibility, Sustainability (primary)To collect data on recruitment and pre-post data on prevalence of potentially inappropriate prescribing (PIP) for the purpose of determining sample size for a scale up next phase study (secondary).To conduct cost analysis of the intervention (secondary).

Eligibility Criteria

Inclusion Criteria for patients:Older adults age 65 and aboveCurrently attending Geriatric Medicine Clinicon at least 5 medications.Exclusion Criteria for patients:Those younger than 65Not a Geriatric Medicine outpatient clinic patientOn fewer than 5 medicationsCurrently receiving other pharmacist-related services such as medication therapy management.Non-English, non-Chinese, and non-Malay speaking patients.Patient or caregiver who declines any of the study procedure required within the intervention framework.Inclusion Criteria for implementer:Doctors and pharmacistswho are involved in the delivery or support of the intervention during the implementation period.Exclusion criteria for implementer:Those who are not involved in the implementation of the study.Those who are not involved in the delivery of the intervention.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05756478). StuddyBuddy aggregates publicly available trial information.